Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

PASC: early-phase trial registry

3 of 3 indexed PASC trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

PASC: 3 US clinical trials tracked, 3 recruiting.

PASC is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Louisville, running 1 of these trials.

Enrollment posture brief

Registry condition pasc

OPEN 3 | RECR 100% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

PASC (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near PASC

PASC lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for PASC on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. PASC is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Named interventions

Most-linked intervention names on PASC records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Low-Dose Naltrexone Drug
1 trials
Pyridostigmine Drug
1 trials
accelerated intermittent theta burst stimulation Device
1 trials
Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol Other
1 trials
Osteopathic Manipulative Therapy Long-COVID protocol Other
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on PASC trials. A trial with sites in several states counts in each.

New Mexico 1 trials
Massachusetts 1 trials
Kentucky 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this PASC page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PASC condition card totals 3 registered trials; most-linked intervention Low-Dose Naltrexone; top US site state New Mexico. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.